News | March 07, 2025
Biocon Biologics and Civica collaborate to expand Insulin Aspart access in US
There are 38.4 million people with diabetes in the United States
There are 38.4 million people with diabetes in the United States
Lonza to develop spray-dried formulations for an intranasally-delivered biologic for Iconovo at its Center of Excellence for bioavailability enhancement and inhaled delivery in Bend (US)
Exploring new opportunities within the fast-growing market of microfluidics
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Partnership to Combine AbbVie's Oncology Expertise with EvolveImmune's Proprietary EVOLVE T-Cell Engager Platform to Develop Novel Multispecific Therapeutic Antibodies for Cancer
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
The acquisition is based on an enterprise value of Rs. 1,660 crore
Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to manufacture and supply treatment for various immunological diseases
The companies will combine Nanoform’s Biologics platform with the Celanese VitalDose Drug Delivery platform to further optimize controlled release of biologics
Subscribe To Our Newsletter & Stay Updated
